P
Peter J. Barnes
Researcher at National Institutes of Health
Publications - 1554
Citations - 177909
Peter J. Barnes is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Asthma & COPD. The author has an hindex of 194, co-authored 1530 publications receiving 166618 citations. Previous affiliations of Peter J. Barnes include University of Nebraska Medical Center & Novartis.
Papers
More filters
Journal ArticleDOI
Autoradiographic localization of autonomic receptors in airway smooth muscle. Marked differences between large and small airways.
TL;DR: Autoradiographic methods were used to determine the distribution of autonomic receptors in airway smooth muscle of ferret from trachea to terminal bronchioles, and marked differences were found in the longitudinal distribution of each receptor and in distribution of the various receptors in each caliber airway.
Journal ArticleDOI
Statins enhance the anti-inflammatory effects of inhaled corticosteroids in asthmatic patients through increased induction of indoleamine 2, 3-dioxygenase.
Kittipong Maneechotesuwan,Wuttichai Ekjiratrakul,Kanda Kasetsinsombat,Adisak Wongkajornsilp,Peter J. Barnes +4 more
TL;DR: A statin enhances the anti-inflammatory effect of an inhaled corticosteroid in asthma, and this was mediated through the alteration of IDO activity in macrophages.
Journal ArticleDOI
Drugs for asthma
TL;DR: It seems likely that pharmacology, rather than molecular genetics, will remain the main approach to the further improvement of treatment for asthma, because new, more specific, therapies targeted at specific cytokines are less effective than corticosteroids, whereas more effective therapies carry a risk of side effects that may not be acceptable.
Journal ArticleDOI
Inhaled corticosteroids in COPD: a controversy
TL;DR: It has not been possible to identify any clinical factors that predict corticosteroid responsiveness in COPD patients in the large clinical trials, and there is increasing evidence that high doses of ICS may have detrimental effects on bones and may increase the risk of pneumonia.
Journal ArticleDOI
Effect of Inhaled Furosemide on Metabisulfite- and Methacholine-induced Bronchoconstriction and Nasal Potential Difference in Asthmatic Subjects
TL;DR: Furosemide had no effect on resting lung function, but it caused a significant threefold reduction in sensitivity to MBS, and its effect on direct bronchoconstriction by the inhaled muscarinic agonist methacholine was studied.